Market Outlook
The global Adrenocortical Hormones API market size was valued at USD 2168.3 million in 2022 and is forecast to a readjusted size of USD 3287.3 million by 2029 with a CAGR of 6.1% during review period.
Cortical Hormone, fully called "Adrenal Cortical Hormone", are a group of steroids secreted by adrenal corticosteroids, mainly including glucocorticoids and salt corticosteroids, as well as a small amount of sex hormones, which are important hormones involved in the metabolism of sugar, fat and protein.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
This report is a detailed and comprehensive analysis for global Adrenocortical Hormones API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adrenocortical Hormones API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Adrenocortical Hormones API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Adrenocortical Hormones API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Adrenocortical Hormones API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adrenocortical Hormones API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adrenocortical Hormones API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD
Segmentation By Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segmentation By Application
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Adrenocortical Hormones API Market in 2025?
The Adrenocortical Hormones API market in 2025 is poised for growth due to the increasing prevalence of adrenal disorders like Addison’s disease and Cushing’s syndrome. Enhanced R&D investments and the development of novel therapies are driving innovation. Furthermore, the expanding demand for synthetic and natural hormone replacements in various medical treatments contributes to the market’s strength.
What are the weaknesses in the Adrenocortical Hormones API Market?
The market faces challenges like high production costs and complex regulatory processes, which can hinder the rapid commercialization of new APIs. Limited awareness and availability of specific treatments in certain regions may also slow down the market's potential, especially in low-income countries where access to hormone therapies is restricted.
What opportunities exist for the Adrenocortical Hormones API Market?
With the growing emphasis on personalized medicine and advancements in biotechnology, there is a significant opportunity for the development of more targeted and efficient therapies. Furthermore, increasing healthcare access in emerging economies opens up new markets for Adrenocortical Hormones APIs. The rising trend in preventive healthcare and chronic disease management offers long-term growth potential for the sector.
What threats could impact the Adrenocortical Hormones API Market?
The Adrenocortical Hormones API market is vulnerable to price fluctuations and regulatory changes that could impact market dynamics. The increasing competition from generic drugs, coupled with the risk of stringent regulations in major markets like the US and Europe, could reduce profit margins. Additionally, the market could be affected by potential supply chain disruptions, especially in the sourcing of raw materials.
Market PESTEL Analysis
What are the political factors affecting the Adrenocortical Hormones API Market in 2025?
Political stability in key markets, such as the US and Europe, directly impacts the regulatory framework for drug manufacturing and distribution. Additionally, changes in healthcare policies, government spending on healthcare, and drug pricing regulations can significantly affect the market’s growth and accessibility.
How do economic factors influence the Adrenocortical Hormones API Market?
Economic conditions such as GDP growth, disposable income levels, and healthcare spending play a crucial role in determining demand. In developed countries, the market benefits from higher healthcare budgets and insurance coverage, while in emerging markets, economic constraints may limit access to these therapies. The cost of production and raw materials is also influenced by the global economic climate.
What social factors impact the Adrenocortical Hormones API Market?
An aging population and the increasing awareness of chronic diseases drive demand for adrenocortical hormone therapies. There is also a growing acceptance of hormone replacement therapies in both developed and developing countries. Social trends toward personalized medicine and preventive healthcare further bolster market growth.
How does technology affect the Adrenocortical Hormones API Market?
Technological advancements in drug development and biotechnology are key drivers for this market. Innovations in synthetic hormone production, enhanced drug delivery systems, and improved diagnostic tools for adrenal diseases are enhancing the effectiveness and availability of treatments, thereby expanding the market.
What environmental factors are relevant to the Adrenocortical Hormones API Market?
Environmental sustainability is becoming more important, particularly in pharmaceutical manufacturing. Companies are increasingly adopting eco-friendly practices to reduce their environmental footprint. Moreover, the availability of raw materials needed to synthesize these hormones may be impacted by environmental factors, such as climate change or resource scarcity.
How do legal factors impact the Adrenocortical Hormones API Market?
Strict regulatory frameworks and patent laws play a significant role in shaping the market dynamics. Compliance with FDA regulations, European Medicines Agency guidelines, and other regional requirements is crucial for manufacturers. Patent expirations can open the door for generics, increasing competition and potentially reducing market profitability for original manufacturers.
Market SIPOC Analysis
Who are the suppliers in the Adrenocortical Hormones API Market 2025?
Suppliers include pharmaceutical raw material providers, manufacturers of synthetic hormones, and biotech companies specializing in hormone production. Additionally, suppliers of packaging materials and suppliers for research and development (R&D) of new therapeutic solutions play a critical role in the supply chain.
What are the inputs required for the Adrenocortical Hormones API Market?
Inputs required include raw materials such as adrenal gland extracts or synthetic compounds, specialized equipment for manufacturing, skilled labor for research and development, and regulatory approvals. Additionally, technology for synthesizing and testing the quality of hormones is a key input for ensuring market supply.
What are the processes involved in the Adrenocortical Hormones API Market?
The process begins with the research and development phase, followed by the production of hormone APIs, quality testing, and regulatory compliance checks. Afterward, manufacturing processes include extraction or synthesis, purification, and formulation. Finally, distribution networks handle the logistics of delivering the finished products to pharmaceutical companies or directly to healthcare providers.
Who are the customers in the Adrenocortical Hormones API Market?
Customers include pharmaceutical companies that manufacture finished dosage forms of hormone replacement therapies, hospitals, clinics, and healthcare providers offering treatments for conditions such as Addison’s disease or Cushing’s syndrome. Additionally, large healthcare distributors and even direct consumers may represent customers in some markets.
What are the outputs of the Adrenocortical Hormones API Market?
The primary outputs are high-quality adrenocortical hormone APIs in various forms, such as tablets, injectables, or topical treatments. These APIs are then used in the production of hormone replacement drugs. Other outputs include regulatory documentation, quality assurance certificates, and comprehensive product reports for healthcare providers.
Market Porter's Five Forces
How intense is the threat of new entrants in the Adrenocortical Hormones API Market?
The threat of new entrants is moderate. While the market has attractive growth prospects, barriers to entry, such as high capital investment, strict regulatory requirements, and the need for specialized manufacturing technology, make it difficult for new companies to break into the market easily. Additionally, established players with strong brand recognition and patents can further deter newcomers.
How strong is the bargaining power of suppliers in the Adrenocortical Hormones API Market?
The bargaining power of suppliers is moderate to high. Since the production of adrenocortical hormones often requires specialized raw materials and processes, a limited number of suppliers control the quality and availability of these inputs. However, as more suppliers enter the market, the power of individual suppliers may decrease, leading to better pricing flexibility.
How strong is the bargaining power of buyers in the Adrenocortical Hormones API Market?
The bargaining power of buyers is moderate. Buyers, including pharmaceutical companies and healthcare providers, may have some leverage when sourcing APIs in bulk, particularly when there are multiple suppliers. However, due to the specialized nature of these hormones and the limited number of reliable suppliers, buyers may be willing to accept higher prices for high-quality, consistent products.
What is the threat of substitute products in the Adrenocortical Hormones API Market?
The threat of substitutes is low. Adrenocortical hormone APIs are essential for treating specific adrenal disorders, and alternatives are limited. While some alternative treatments, such as gene therapies or other hormone analogs, are being explored, they are still in early stages of development, making traditional adrenocortical hormone therapies the most effective option for patients.
How intense is the competitive rivalry in the Adrenocortical Hormones API Market?
The competitive rivalry in the Adrenocortical Hormones API Market is moderate. While the market is growing, it is highly specialized, and only a few large players dominate the industry. Competition mainly revolves around the ability to innovate, comply with regulatory standards, and maintain consistent product quality. However, the market remains fragmented with room for smaller players and niche manufacturers to grow.
Market Upstream Analysis
What are the key raw materials required in the Adrenocortical Hormones API Market?
The key raw materials include adrenal gland extracts, synthetic precursors, and specialized chemicals for hormone synthesis. These materials are crucial for producing high-quality APIs that meet the regulatory standards. Some processes also rely on biotechnological inputs to develop synthetic analogs or bio-identical hormones.
What are the primary sources of these raw materials?
Raw materials are primarily sourced from both animal and synthetic origins. For natural adrenocortical hormones, adrenal glands from livestock are harvested under strict regulatory oversight. Alternatively, synthetic production methods using chemical or biotechnological processes are becoming increasingly popular to meet demand for more consistent and scalable hormone production.
How is the supply chain for these raw materials structured?
The supply chain begins with suppliers of raw materials, which are then processed by specialized manufacturers who extract or synthesize hormones. These intermediates are further refined and undergo quality testing before being sold to pharmaceutical companies or API manufacturers. The chain also involves regulatory bodies ensuring the safety and efficacy of the raw materials.
What challenges exist in securing upstream raw materials?
Challenges include the limited availability of certain raw materials, especially for natural adrenocortical hormones, which are subject to fluctuations in livestock availability and regulatory restrictions. Additionally, the complexity of the production process for synthetic hormones may increase costs and lead times. Regulatory compliance and ethical considerations, particularly concerning animal-derived materials, also present hurdles.
How do technological advancements impact the upstream process?
Technological advancements are improving the efficiency and consistency of hormone synthesis, reducing dependency on animal-derived raw materials. Biotechnology innovations enable more sustainable, cost-effective methods of producing hormones, particularly through recombinant DNA technology. These advancements help stabilize supply chains and improve overall product quality.
What role do regulations play in the upstream process?
Regulations play a significant role in ensuring the safety and quality of raw materials used in the production of Adrenocortical Hormone APIs. Strict guidelines govern the sourcing, handling, and processing of animal-derived materials, as well as the manufacturing practices for synthetic hormones. Compliance with international standards is crucial to maintaining market access and meeting consumer health and safety expectations.
Market Midstream Analysis
What are the key activities in the midstream process of the Adrenocortical Hormones API Market?
The midstream process primarily involves the manufacturing and refinement of raw materials into active pharmaceutical ingredients (APIs). This includes the extraction of natural hormones, the synthesis of synthetic analogs, purification, quality control, and regulatory compliance testing to ensure the APIs meet the required standards for therapeutic use.
What are the major challenges faced in the midstream process?
Major challenges include maintaining consistent quality control during large-scale production, meeting strict regulatory standards, and ensuring efficient manufacturing processes. The complexity of producing both synthetic and natural adrenocortical hormones adds to the difficulty, as any discrepancies in production or impurities in the API can affect the final drug's safety and efficacy.
How do quality control and regulatory compliance impact the midstream process?
Quality control and regulatory compliance are paramount in the midstream process. Manufacturers must comply with stringent regulations such as Good Manufacturing Practices (GMP) and ensure their APIs are free from contamination. These steps require rigorous testing for potency, purity, and stability, making the midstream phase both time-consuming and costly.
What role do manufacturing facilities play in the midstream process?
Manufacturing facilities are central to the midstream process, as they house the equipment and expertise required for large-scale production and refinement of adrenocortical hormones. These facilities must meet regulatory standards and invest in advanced technologies to ensure product consistency, reduce waste, and optimize efficiency in hormone production.
How do technological advancements affect the midstream process?
Technological advancements, particularly in automation, process optimization, and biotechnology, enhance the efficiency and scalability of the midstream process. For example, innovations like recombinant DNA technology and continuous manufacturing processes allow for higher yields, improved quality, and cost reduction, driving greater efficiency in API production.
What is the role of partnerships and collaborations in the midstream process?
Partnerships with research institutions, technology providers, and regulatory consultants play a vital role in the midstream process. These collaborations help companies stay ahead in terms of innovation, access specialized manufacturing technologies, and navigate the complex regulatory landscape, ultimately ensuring that their APIs meet global market demands.
Market Downstream Analysis
What are the key activities in the downstream process of the Adrenocortical Hormones API Market?
The downstream process involves the formulation of APIs into finished pharmaceutical products, such as tablets, injectables, or topical treatments. These products are then packaged, marketed, and distributed to hospitals, pharmacies, and healthcare providers. Distribution networks and sales channels are crucial for getting the final products to consumers.
What challenges are faced in the downstream process?
The primary challenges in the downstream process include ensuring consistent product availability, managing the complexities of distribution, and navigating pricing pressures from healthcare systems. Additionally, fluctuations in demand, changes in healthcare regulations, and the growing competition from generic drug manufacturers add pressure on downstream operations.
How does distribution impact the downstream process?
Distribution is critical in the downstream process as it ensures the timely and efficient delivery of products to end-users. A well-structured distribution network, including wholesalers, pharmacies, and healthcare providers, can significantly reduce the time between production and patient access. However, logistics issues and regional healthcare infrastructure limitations can pose challenges.
What role does pricing play in the downstream process?
Pricing plays a significant role in the downstream process, as it influences demand and accessibility. The price of adrenocortical hormone APIs directly affects the cost of finished products, which in turn impacts affordability for patients. Price control policies, insurance coverage, and market competition drive pricing strategies and affect product uptake.
How do market dynamics affect the downstream process?
Market dynamics, including the entry of generic competitors, evolving patient needs, and healthcare policy shifts, have a profound impact on downstream activities. For example, the rise of generic alternatives to branded adrenocortical hormone products can reduce market share for original manufacturers, forcing them to adapt their pricing, distribution, and marketing strategies.
What role do marketing and awareness play in the downstream process?
Marketing and awareness are essential in educating healthcare providers and patients about the availability and benefits of adrenocortical hormone therapies. Effective marketing campaigns can boost product adoption, while increasing awareness about adrenal disorders can create demand. Collaboration with healthcare professionals for better treatment understanding further enhances market penetration.
Chapter 1, to describe Adrenocortical Hormones API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adrenocortical Hormones API, with price, sales, revenue and global market share of Adrenocortical Hormones API from 2018 to 2023.
Chapter 3, the Adrenocortical Hormones API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adrenocortical Hormones API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adrenocortical Hormones API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adrenocortical Hormones API.
Chapter 14 and 15, to describe Adrenocortical Hormones API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Adrenocortical Hormones API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adrenocortical Hormones API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prednisone Series
1.3.3 Dexamethasone Series
1.3.4 Betamethasone Series
1.3.5 Hydrocortisone Series
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Adrenocortical Hormones API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Injectable Drugs
1.4.3 Oral Drugs
1.4.4 For External Use Drugs
1.4.5 Inhalation Drugs
1.5 Global Adrenocortical Hormones API Market Size & Forecast
1.5.1 Global Adrenocortical Hormones API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adrenocortical Hormones API Sales Quantity (2018-2029)
1.5.3 Global Adrenocortical Hormones API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer CentreOne
2.1.1 Pfizer CentreOne Details
2.1.2 Pfizer CentreOne Major Business
2.1.3 Pfizer CentreOne Adrenocortical Hormones API Product and Services
2.1.4 Pfizer CentreOne Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer CentreOne Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Adrenocortical Hormones API Product and Services
2.2.4 Sanofi Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Adrenocortical Hormones API Product and Services
2.3.4 GlaxoSmithKline Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Tianjin Pharmaceutical Group Co., Ltd.
2.4.1 Tianjin Pharmaceutical Group Co., Ltd. Details
2.4.2 Tianjin Pharmaceutical Group Co., Ltd. Major Business
2.4.3 Tianjin Pharmaceutical Group Co., Ltd. Adrenocortical Hormones API Product and Services
2.4.4 Tianjin Pharmaceutical Group Co., Ltd. Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
2.5 Xianju Pharma
2.5.1 Xianju Pharma Details
2.5.2 Xianju Pharma Major Business
2.5.3 Xianju Pharma Adrenocortical Hormones API Product and Services
2.5.4 Xianju Pharma Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Xianju Pharma Recent Developments/Updates
2.6 Guangdong VTR Bio-Tech Co., Ltd
2.6.1 Guangdong VTR Bio-Tech Co., Ltd Details
2.6.2 Guangdong VTR Bio-Tech Co., Ltd Major Business
2.6.3 Guangdong VTR Bio-Tech Co., Ltd Adrenocortical Hormones API Product and Services
2.6.4 Guangdong VTR Bio-Tech Co., Ltd Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Guangdong VTR Bio-Tech Co., Ltd Recent Developments/Updates
2.7 Symbiotec Pharmalab
2.7.1 Symbiotec Pharmalab Details
2.7.2 Symbiotec Pharmalab Major Business
2.7.3 Symbiotec Pharmalab Adrenocortical Hormones API Product and Services
2.7.4 Symbiotec Pharmalab Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Symbiotec Pharmalab Recent Developments/Updates
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Adrenocortical Hormones API Product and Services
2.8.4 Sun Pharmaceutical Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sun Pharmaceutical Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Adrenocortical Hormones API Product and Services
2.9.4 Cipla Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cipla Recent Developments/Updates
2.10 Hovione
2.10.1 Hovione Details
2.10.2 Hovione Major Business
2.10.3 Hovione Adrenocortical Hormones API Product and Services
2.10.4 Hovione Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hovione Recent Developments/Updates
2.11 Shandong Xinhua Pharmaceutical Company Limited
2.11.1 Shandong Xinhua Pharmaceutical Company Limited Details
2.11.2 Shandong Xinhua Pharmaceutical Company Limited Major Business
2.11.3 Shandong Xinhua Pharmaceutical Company Limited Adrenocortical Hormones API Product and Services
2.11.4 Shandong Xinhua Pharmaceutical Company Limited Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
2.12 Steroid SpA
2.12.1 Steroid SpA Details
2.12.2 Steroid SpA Major Business
2.12.3 Steroid SpA Adrenocortical Hormones API Product and Services
2.12.4 Steroid SpA Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Steroid SpA Recent Developments/Updates
2.13 Junye Pharmaceutical Co., Ltd.
2.13.1 Junye Pharmaceutical Co., Ltd. Details
2.13.2 Junye Pharmaceutical Co., Ltd. Major Business
2.13.3 Junye Pharmaceutical Co., Ltd. Adrenocortical Hormones API Product and Services
2.13.4 Junye Pharmaceutical Co., Ltd. Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Junye Pharmaceutical Co., Ltd. Recent Developments/Updates
2.14 Avik Pharmaceutical
2.14.1 Avik Pharmaceutical Details
2.14.2 Avik Pharmaceutical Major Business
2.14.3 Avik Pharmaceutical Adrenocortical Hormones API Product and Services
2.14.4 Avik Pharmaceutical Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Avik Pharmaceutical Recent Developments/Updates
2.15 Great Pacific Exports
2.15.1 Great Pacific Exports Details
2.15.2 Great Pacific Exports Major Business
2.15.3 Great Pacific Exports Adrenocortical Hormones API Product and Services
2.15.4 Great Pacific Exports Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Great Pacific Exports Recent Developments/Updates
2.16 Shanghai New Hualian Pharmaceutical Co., Ltd
2.16.1 Shanghai New Hualian Pharmaceutical Co., Ltd Details
2.16.2 Shanghai New Hualian Pharmaceutical Co., Ltd Major Business
2.16.3 Shanghai New Hualian Pharmaceutical Co., Ltd Adrenocortical Hormones API Product and Services
2.16.4 Shanghai New Hualian Pharmaceutical Co., Ltd Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Shanghai New Hualian Pharmaceutical Co., Ltd Recent Developments/Updates
2.17 Shandong Taihua Bio & Tech Stock Co., Ltd
2.17.1 Shandong Taihua Bio & Tech Stock Co., Ltd Details
2.17.2 Shandong Taihua Bio & Tech Stock Co., Ltd Major Business
2.17.3 Shandong Taihua Bio & Tech Stock Co., Ltd Adrenocortical Hormones API Product and Services
2.17.4 Shandong Taihua Bio & Tech Stock Co., Ltd Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Shandong Taihua Bio & Tech Stock Co., Ltd Recent Developments/Updates
2.18 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
2.18.1 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Details
2.18.2 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Major Business
2.18.3 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Adrenocortical Hormones API Product and Services
2.18.4 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Recent Developments/Updates
2.19 Teva
2.19.1 Teva Details
2.19.2 Teva Major Business
2.19.3 Teva Adrenocortical Hormones API Product and Services
2.19.4 Teva Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Teva Recent Developments/Updates
2.20 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
2.20.1 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Details
2.20.2 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Major Business
2.20.3 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Adrenocortical Hormones API Product and Services
2.20.4 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Recent Developments/Updates
2.21 Jiangsu Lianhuan Pharmaceutical Co., Ltd
2.21.1 Jiangsu Lianhuan Pharmaceutical Co., Ltd Details
2.21.2 Jiangsu Lianhuan Pharmaceutical Co., Ltd Major Business
2.21.3 Jiangsu Lianhuan Pharmaceutical Co., Ltd Adrenocortical Hormones API Product and Services
2.21.4 Jiangsu Lianhuan Pharmaceutical Co., Ltd Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Jiangsu Lianhuan Pharmaceutical Co., Ltd Recent Developments/Updates
2.22 Shandong Sito Bio-technology CO., LTD
2.22.1 Shandong Sito Bio-technology CO., LTD Details
2.22.2 Shandong Sito Bio-technology CO., LTD Major Business
2.22.3 Shandong Sito Bio-technology CO., LTD Adrenocortical Hormones API Product and Services
2.22.4 Shandong Sito Bio-technology CO., LTD Adrenocortical Hormones API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Shandong Sito Bio-technology CO., LTD Recent Developments/Updates
3 Competitive Environment: Adrenocortical Hormones API by Manufacturer
3.1 Global Adrenocortical Hormones API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adrenocortical Hormones API Revenue by Manufacturer (2018-2023)
3.3 Global Adrenocortical Hormones API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adrenocortical Hormones API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adrenocortical Hormones API Manufacturer Market Share in 2022
3.4.2 Top 6 Adrenocortical Hormones API Manufacturer Market Share in 2022
3.5 Adrenocortical Hormones API Market: Overall Company Footprint Analysis
3.5.1 Adrenocortical Hormones API Market: Region Footprint
3.5.2 Adrenocortical Hormones API Market: Company Product Type Footprint
3.5.3 Adrenocortical Hormones API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Adrenocortical Hormones API Market Size by Region
4.1.1 Global Adrenocortical Hormones API Sales Quantity by Region (2018-2029)
4.1.2 Global Adrenocortical Hormones API Consumption Value by Region (2018-2029)
4.1.3 Global Adrenocortical Hormones API Average Price by Region (2018-2029)
4.2 North America Adrenocortical Hormones API Consumption Value (2018-2029)
4.3 Europe Adrenocortical Hormones API Consumption Value (2018-2029)
4.4 Asia-Pacific Adrenocortical Hormones API Consumption Value (2018-2029)
4.5 South America Adrenocortical Hormones API Consumption Value (2018-2029)
4.6 Middle East and Africa Adrenocortical Hormones API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
5.2 Global Adrenocortical Hormones API Consumption Value by Type (2018-2029)
5.3 Global Adrenocortical Hormones API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
6.2 Global Adrenocortical Hormones API Consumption Value by Application (2018-2029)
6.3 Global Adrenocortical Hormones API Average Price by Application (2018-2029)
7 North America
7.1 North America Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
7.2 North America Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
7.3 North America Adrenocortical Hormones API Market Size by Country
7.3.1 North America Adrenocortical Hormones API Sales Quantity by Country (2018-2029)
7.3.2 North America Adrenocortical Hormones API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
8.2 Europe Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
8.3 Europe Adrenocortical Hormones API Market Size by Country
8.3.1 Europe Adrenocortical Hormones API Sales Quantity by Country (2018-2029)
8.3.2 Europe Adrenocortical Hormones API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adrenocortical Hormones API Market Size by Region
9.3.1 Asia-Pacific Adrenocortical Hormones API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adrenocortical Hormones API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
10.2 South America Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
10.3 South America Adrenocortical Hormones API Market Size by Country
10.3.1 South America Adrenocortical Hormones API Sales Quantity by Country (2018-2029)
10.3.2 South America Adrenocortical Hormones API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Adrenocortical Hormones API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adrenocortical Hormones API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adrenocortical Hormones API Market Size by Country
11.3.1 Middle East & Africa Adrenocortical Hormones API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adrenocortical Hormones API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Adrenocortical Hormones API Market Drivers
12.2 Adrenocortical Hormones API Market Restraints
12.3 Adrenocortical Hormones API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Adrenocortical Hormones API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adrenocortical Hormones API
13.3 Adrenocortical Hormones API Production Process
13.4 Adrenocortical Hormones API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adrenocortical Hormones API Typical Distributors
14.3 Adrenocortical Hormones API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Adrenocortical Hormones API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adrenocortical Hormones API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer CentreOne Major Business
Table 5. Pfizer CentreOne Adrenocortical Hormones API Product and Services
Table 6. Pfizer CentreOne Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer CentreOne Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Adrenocortical Hormones API Product and Services
Table 11. Sanofi Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Adrenocortical Hormones API Product and Services
Table 16. GlaxoSmithKline Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Tianjin Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Tianjin Pharmaceutical Group Co., Ltd. Major Business
Table 20. Tianjin Pharmaceutical Group Co., Ltd. Adrenocortical Hormones API Product and Services
Table 21. Tianjin Pharmaceutical Group Co., Ltd. Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 23. Xianju Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Xianju Pharma Major Business
Table 25. Xianju Pharma Adrenocortical Hormones API Product and Services
Table 26. Xianju Pharma Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Xianju Pharma Recent Developments/Updates
Table 28. Guangdong VTR Bio-Tech Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Guangdong VTR Bio-Tech Co., Ltd Major Business
Table 30. Guangdong VTR Bio-Tech Co., Ltd Adrenocortical Hormones API Product and Services
Table 31. Guangdong VTR Bio-Tech Co., Ltd Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Guangdong VTR Bio-Tech Co., Ltd Recent Developments/Updates
Table 33. Symbiotec Pharmalab Basic Information, Manufacturing Base and Competitors
Table 34. Symbiotec Pharmalab Major Business
Table 35. Symbiotec Pharmalab Adrenocortical Hormones API Product and Services
Table 36. Symbiotec Pharmalab Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Symbiotec Pharmalab Recent Developments/Updates
Table 38. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceutical Major Business
Table 40. Sun Pharmaceutical Adrenocortical Hormones API Product and Services
Table 41. Sun Pharmaceutical Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sun Pharmaceutical Recent Developments/Updates
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Major Business
Table 45. Cipla Adrenocortical Hormones API Product and Services
Table 46. Cipla Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cipla Recent Developments/Updates
Table 48. Hovione Basic Information, Manufacturing Base and Competitors
Table 49. Hovione Major Business
Table 50. Hovione Adrenocortical Hormones API Product and Services
Table 51. Hovione Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hovione Recent Developments/Updates
Table 53. Shandong Xinhua Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 54. Shandong Xinhua Pharmaceutical Company Limited Major Business
Table 55. Shandong Xinhua Pharmaceutical Company Limited Adrenocortical Hormones API Product and Services
Table 56. Shandong Xinhua Pharmaceutical Company Limited Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
Table 58. Steroid SpA Basic Information, Manufacturing Base and Competitors
Table 59. Steroid SpA Major Business
Table 60. Steroid SpA Adrenocortical Hormones API Product and Services
Table 61. Steroid SpA Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Steroid SpA Recent Developments/Updates
Table 63. Junye Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Junye Pharmaceutical Co., Ltd. Major Business
Table 65. Junye Pharmaceutical Co., Ltd. Adrenocortical Hormones API Product and Services
Table 66. Junye Pharmaceutical Co., Ltd. Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Junye Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 68. Avik Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Avik Pharmaceutical Major Business
Table 70. Avik Pharmaceutical Adrenocortical Hormones API Product and Services
Table 71. Avik Pharmaceutical Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Avik Pharmaceutical Recent Developments/Updates
Table 73. Great Pacific Exports Basic Information, Manufacturing Base and Competitors
Table 74. Great Pacific Exports Major Business
Table 75. Great Pacific Exports Adrenocortical Hormones API Product and Services
Table 76. Great Pacific Exports Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Great Pacific Exports Recent Developments/Updates
Table 78. Shanghai New Hualian Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 79. Shanghai New Hualian Pharmaceutical Co., Ltd Major Business
Table 80. Shanghai New Hualian Pharmaceutical Co., Ltd Adrenocortical Hormones API Product and Services
Table 81. Shanghai New Hualian Pharmaceutical Co., Ltd Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Shanghai New Hualian Pharmaceutical Co., Ltd Recent Developments/Updates
Table 83. Shandong Taihua Bio & Tech Stock Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Shandong Taihua Bio & Tech Stock Co., Ltd Major Business
Table 85. Shandong Taihua Bio & Tech Stock Co., Ltd Adrenocortical Hormones API Product and Services
Table 86. Shandong Taihua Bio & Tech Stock Co., Ltd Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Shandong Taihua Bio & Tech Stock Co., Ltd Recent Developments/Updates
Table 88. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Basic Information, Manufacturing Base and Competitors
Table 89. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Major Business
Table 90. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Adrenocortical Hormones API Product and Services
Table 91. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP) Recent Developments/Updates
Table 93. Teva Basic Information, Manufacturing Base and Competitors
Table 94. Teva Major Business
Table 95. Teva Adrenocortical Hormones API Product and Services
Table 96. Teva Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Teva Recent Developments/Updates
Table 98. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 99. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Major Business
Table 100. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Adrenocortical Hormones API Product and Services
Table 101. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 103. Jiangsu Lianhuan Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu Lianhuan Pharmaceutical Co., Ltd Major Business
Table 105. Jiangsu Lianhuan Pharmaceutical Co., Ltd Adrenocortical Hormones API Product and Services
Table 106. Jiangsu Lianhuan Pharmaceutical Co., Ltd Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jiangsu Lianhuan Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Shandong Sito Bio-technology CO., LTD Basic Information, Manufacturing Base and Competitors
Table 109. Shandong Sito Bio-technology CO., LTD Major Business
Table 110. Shandong Sito Bio-technology CO., LTD Adrenocortical Hormones API Product and Services
Table 111. Shandong Sito Bio-technology CO., LTD Adrenocortical Hormones API Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Shandong Sito Bio-technology CO., LTD Recent Developments/Updates
Table 113. Global Adrenocortical Hormones API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 114. Global Adrenocortical Hormones API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 115. Global Adrenocortical Hormones API Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 116. Market Position of Manufacturers in Adrenocortical Hormones API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 117. Head Office and Adrenocortical Hormones API Production Site of Key Manufacturer
Table 118. Adrenocortical Hormones API Market: Company Product Type Footprint
Table 119. Adrenocortical Hormones API Market: Company Product Application Footprint
Table 120. Adrenocortical Hormones API New Market Entrants and Barriers to Market Entry
Table 121. Adrenocortical Hormones API Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Adrenocortical Hormones API Sales Quantity by Region (2018-2023) & (Tons)
Table 123. Global Adrenocortical Hormones API Sales Quantity by Region (2024-2029) & (Tons)
Table 124. Global Adrenocortical Hormones API Consumption Value by Region (2018-2023) & (USD Million)
Table 125. Global Adrenocortical Hormones API Consumption Value by Region (2024-2029) & (USD Million)
Table 126. Global Adrenocortical Hormones API Average Price by Region (2018-2023) & (USD/Kg)
Table 127. Global Adrenocortical Hormones API Average Price by Region (2024-2029) & (USD/Kg)
Table 128. Global Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 129. Global Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 130. Global Adrenocortical Hormones API Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Global Adrenocortical Hormones API Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Global Adrenocortical Hormones API Average Price by Type (2018-2023) & (USD/Kg)
Table 133. Global Adrenocortical Hormones API Average Price by Type (2024-2029) & (USD/Kg)
Table 134. Global Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 135. Global Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 136. Global Adrenocortical Hormones API Consumption Value by Application (2018-2023) & (USD Million)
Table 137. Global Adrenocortical Hormones API Consumption Value by Application (2024-2029) & (USD Million)
Table 138. Global Adrenocortical Hormones API Average Price by Application (2018-2023) & (USD/Kg)
Table 139. Global Adrenocortical Hormones API Average Price by Application (2024-2029) & (USD/Kg)
Table 140. North America Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 141. North America Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 142. North America Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 143. North America Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 144. North America Adrenocortical Hormones API Sales Quantity by Country (2018-2023) & (Tons)
Table 145. North America Adrenocortical Hormones API Sales Quantity by Country (2024-2029) & (Tons)
Table 146. North America Adrenocortical Hormones API Consumption Value by Country (2018-2023) & (USD Million)
Table 147. North America Adrenocortical Hormones API Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Europe Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 149. Europe Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 150. Europe Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 151. Europe Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 152. Europe Adrenocortical Hormones API Sales Quantity by Country (2018-2023) & (Tons)
Table 153. Europe Adrenocortical Hormones API Sales Quantity by Country (2024-2029) & (Tons)
Table 154. Europe Adrenocortical Hormones API Consumption Value by Country (2018-2023) & (USD Million)
Table 155. Europe Adrenocortical Hormones API Consumption Value by Country (2024-2029) & (USD Million)
Table 156. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 157. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 158. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 159. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 160. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Region (2018-2023) & (Tons)
Table 161. Asia-Pacific Adrenocortical Hormones API Sales Quantity by Region (2024-2029) & (Tons)
Table 162. Asia-Pacific Adrenocortical Hormones API Consumption Value by Region (2018-2023) & (USD Million)
Table 163. Asia-Pacific Adrenocortical Hormones API Consumption Value by Region (2024-2029) & (USD Million)
Table 164. South America Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 165. South America Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 166. South America Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 167. South America Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 168. South America Adrenocortical Hormones API Sales Quantity by Country (2018-2023) & (Tons)
Table 169. South America Adrenocortical Hormones API Sales Quantity by Country (2024-2029) & (Tons)
Table 170. South America Adrenocortical Hormones API Consumption Value by Country (2018-2023) & (USD Million)
Table 171. South America Adrenocortical Hormones API Consumption Value by Country (2024-2029) & (USD Million)
Table 172. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Type (2018-2023) & (Tons)
Table 173. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Type (2024-2029) & (Tons)
Table 174. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Application (2018-2023) & (Tons)
Table 175. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Application (2024-2029) & (Tons)
Table 176. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Region (2018-2023) & (Tons)
Table 177. Middle East & Africa Adrenocortical Hormones API Sales Quantity by Region (2024-2029) & (Tons)
Table 178. Middle East & Africa Adrenocortical Hormones API Consumption Value by Region (2018-2023) & (USD Million)
Table 179. Middle East & Africa Adrenocortical Hormones API Consumption Value by Region (2024-2029) & (USD Million)
Table 180. Adrenocortical Hormones API Raw Material
Table 181. Key Manufacturers of Adrenocortical Hormones API Raw Materials
Table 182. Adrenocortical Hormones API Typical Distributors
Table 183. Adrenocortical Hormones API Typical Customers
List of Figures
Figure 1. Adrenocortical Hormones API Picture
Figure 2. Global Adrenocortical Hormones API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adrenocortical Hormones API Consumption Value Market Share by Type in 2022
Figure 4. Prednisone Series Examples
Figure 5. Dexamethasone Series Examples
Figure 6. Betamethasone Series Examples
Figure 7. Hydrocortisone Series Examples
Figure 8. Others Examples
Figure 9. Global Adrenocortical Hormones API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Adrenocortical Hormones API Consumption Value Market Share by Application in 2022
Figure 11. Injectable Drugs Examples
Figure 12. Oral Drugs Examples
Figure 13. For External Use Drugs Examples
Figure 14. Inhalation Drugs Examples
Figure 15. Global Adrenocortical Hormones API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Adrenocortical Hormones API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Adrenocortical Hormones API Sales Quantity (2018-2029) & (Tons)
Figure 18. Global Adrenocortical Hormones API Average Price (2018-2029) & (USD/Kg)
Figure 19. Global Adrenocortical Hormones API Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Adrenocortical Hormones API Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Adrenocortical Hormones API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Adrenocortical Hormones API Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Adrenocortical Hormones API Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Adrenocortical Hormones API Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Adrenocortical Hormones API Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Adrenocortical Hormones API Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Adrenocortical Hormones API Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Adrenocortical Hormones API Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Adrenocortical Hormones API Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Adrenocortical Hormones API Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Adrenocortical Hormones API Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Adrenocortical Hormones API Average Price by Type (2018-2029) & (USD/Kg)
Figure 34. Global Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Adrenocortical Hormones API Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Adrenocortical Hormones API Average Price by Application (2018-2029) & (USD/Kg)
Figure 37. North America Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Adrenocortical Hormones API Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Adrenocortical Hormones API Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Adrenocortical Hormones API Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Adrenocortical Hormones API Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Adrenocortical Hormones API Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Adrenocortical Hormones API Consumption Value Market Share by Region (2018-2029)
Figure 57. China Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Adrenocortical Hormones API Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Adrenocortical Hormones API Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Adrenocortical Hormones API Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Adrenocortical Hormones API Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Adrenocortical Hormones API Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Adrenocortical Hormones API Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Adrenocortical Hormones API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Adrenocortical Hormones API Market Drivers
Figure 78. Adrenocortical Hormones API Market Restraints
Figure 79. Adrenocortical Hormones API Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Adrenocortical Hormones API in 2022
Figure 82. Manufacturing Process Analysis of Adrenocortical Hormones API
Figure 83. Adrenocortical Hormones API Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
